Protagenic Therapeutics exec chair Garo H. Armen acquires 685 common shares worth $150.7
PTIX•Insider purchase disclosed
- Protagenic Therapeutics director, Executive Chair and Principal Officer Garo H. Armen bought 685 common shares at $0.22 each.
- Armen’s direct common stock holdings rose to 31,979 shares.
